We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not when Sir Marc said Inflection point was 2021;As the song says What's another year(when you have lost everything you own)
HFH ... sadly i agree. I just cannot wait another year to get to 1.5p or 2p. I am so under with so many shares, i am going to have to make a decisions on this soon. I am definately not deramping since I also believe in 2023, this will be a huge multi bagger from this price but just depends if you can keep money locked away for that long.
It’s obvious why people aren’t buying. Vlad put the CAR-T IND back to later this year and the CDX IND into late next year. They’ll be other updates along the way, especially on CBR but those two are arguably the inflection points. You either wait or you don’t and it appears most don’t want to. Personally I’m not surprised, I’ll wait but a lot have overstretched and can’t wait that long.
Hedgehogarth...there are plenty that have gone up in 2022...try AstraZeneca!!
Lots of angry people on here...try these, might help keep the blood pressure down:
https://www.fruitflowplus.com
Scientifically proven to prevent spiky blood platelets and approved by the EU!!
If some of you think this is such a bad share, why are you still here? Paid rampers and derampers spoil these boards. Constant winging and wining is painful. Investments take time in the pharmaceuticals. Let the work continue and one day we will all hopefully be rewarded. If you can't wait,or are just staying to be negative, then move on. I have a lot invested in this share and will wait patiently for the results. Good luck to the proper investors, no time for the others...
One buy today above £1k....absolute joke.
Hedgehogarth ... that is irrelevant and the same deflection JHFH uses. Yes the market is down but as I said, if I saw a bargain, I would be buying. Activity in this stock is a joke and there is literally no interest. I just dont know where the buyers are going to come from to get this even to 1.5p !!!
Show me a share that is not in the doldrums...
AO are now down 91 per cent vs their lockdown highs
Sorry but the market doesnt think they are positive or this would not be sitting at 1.3p!!! Again that is what i am missing ... is it distrust in Vlad or distrust in the science since this has virtually no buyers even at this price ... shocking !!!
In 12 months the bank account will be running on fumes, so let's hope we get some news before then..
We have had 4 possitive rns in last 4 months and sp is still at rock bottom why do people crave an rns ? The shorters love them only way this will fly is when we go to trials end of.. so kick ba k and chill for 12 months my thoughts only
So boring on here...
Nobody who has listened to Vlad or more knowledgeable posters on here should be expecting an imminent RNS.
Based on everything in the public domain - Its easy to know where Hemo are at right now
I'm looking forward to the Zoom call - I dont expect to learn much know, but may pick up a little more information
Fruitflow has EFSA Authorisation :definitely not for piles:excellent product:run badly by the company;bit like Hemo a ONE MAN BAND:God forbid anything happened to Vlad;then we all would be up site creek without the paddle
Weren't the happy clappers predicting an RNS before the big zoom meeting..
Ps, there wont be any big revelations tomorrow...its just a pep talk.
JHFH ... I am definately not negative about the future. This is a crazy low price. We are on the cusp of news (well thats what we all expect), progress is being made on all fronts and we have a webinar tomorrow. What could be bad about that ..
Only the fact that its frustration for all of us who have supported this stock and waited a long time only to be still massively red. We wait every day for something to happen or as you say for people to recognise the true value but instead they pump money into others like GDR or NNN and make a solid 100% over 2 days.
We just cannot keep defending this company for ever. Yes we have a choice to sell out but we are so at a loss have to just pray that something comes good. I hate traders but at least they bring visibility and volume to stock and that is not happening here. A small volume and this moves fast yet there are never any real buyers expect people like us just averaging down.
Thats the damn part I cannot understand ... If this was such an undervalued stock, there would be consistent volume every day and not 1 blue day and then 20 reds. Thats the fact with this stock and no one can explain why that is the case !!!!
We dont need an RNS, we dont need progress, we just need volume and visibility.
2 years ago today the mCap of Hemogenyx was £26.9 Million
In those 2 years Hemogenyx have announced CAR-T in partnerships now with Penn and Wu-Xi
They have secured multiple patents and filed many more covering antibodies and CBR.
They have announced CBR, a potential treatment for almost all known viruses, bacteria and some malignant cancers.
They have moved to a custom built lab with clean room suitable for manufacturing clinical grade cells both internally and as an external service.
They have multiple ongoing engagements with world names such as Eli Lilly, WuXi, Selenix and god knows who else.
They have ZERO debt and millions more in the bank.
Dont get me wrong, I expect news to come on CDX, CBR and who knows what else, but will people please quit whitewashing over the achievements of the past few years and this obsession with ONLY the next news. I EXPECT RNS;s in the coming weeks and months, but I dont NEED them to continue to hold and add.
2 years HALF the valuation with millions more in the bank, zero debt and massive pipeline growth, if people really cannot look at this company and see the potential worth they need to sell up and move the F on, its exhausting! Thankfully I am off into the city so wont have to see Pumpkins reply about a placing for Covid years ago or some link to some company getting FDA approval for some cream to treat piles or something which, as night follows day, will follow my post.
JHFH ... Agreed but no webinar is going to make this rerate. It needs an official or multiple RNS updates that show real progress on partnerships or something strategic so investors can value this company better. This is going to be stuck until vlad or marketing steps up and gives us something tangible to erase the past mistakes. It's all good being positive among us few people but this needs some real buys like in NNN and GDR today ... we have waited a long time for any restbite and its all getting a little boring and challenging waiting.
Fruitflow;a food supplement? Delays here due to Covid etc:Covid didn't stop Vlad 'milking "shareholders for £2.1 million"then deciding the market was "saturated",Even NNN is performing better than this share
Good to see a more nuanced post Barber, HFH very much agree with your post. Mr India I understand and share your frustration.
Barber, I think you need to understand that for many LTH'ers who defend this company the issue is that the company has been delivering and the fact that the share price has not responded is a huge frustration but not linked to performance. Rather SP has been affected more by external influences and poor sentiment when CLNs were in force resulting in significant dilution. Cashflow, funding, financial stability..... For small companies like this sentiment is everything, CLNs were almost terminal and destroyed sentiment, but had that not happened positive sentiment is what enables companies like Hemo to raise the funds required on the open market so when you believe in the science investors need to remain positive. Its a self fulfilling prophecy, keep positive, SP rises, if company needs to raise its done much higher and less dilution which in itself is positive. People attack and hurt sentiment, SP falls, raises are lower, worse dilution and that hurts SP further. But that's irrelevant now, where the SP is Hemogenyx could never raise even a fraction of future requirements on the open market, it will be down to non dilutive arrangements when they have clinical proof for CAR-T.
You point out Verona on 260mil mCap who only have Ensifentrine, one single candidate which looks like it helps people with COPD, CF, asthma etc. This is great, I dont think its over valued, I think its a very fair price and likely to be worth multiples when sold. But its one treatment and its not in oncology which is where the real money is + 20x Hemos mCap.
The other you point out Provexis plc, mCap of 17mil, again, no issue with the company or their valuation, but they sell a food supplement Fruitflow is £15 for a months supply.
People keep completely whitewashing the progress that Hemogenyx has made over the past few years and using share price to justify this. Reality is in the past 2 years Hemo have moved from a garden shed lab to a clinical grade lab, developed CAR-T to the point of clinical trials and discovered and protected CBR a potential cure for almost all known viruses/bacteria. Along they way they have convinced some major global names to partner up, companies that clearly know what Hemo has works. But they are joining as subordinate or assistant to Hemogenyx, they are not buying as Vlad does not want to sell.
Traders and the like use the SP performance in the past to justify and as evidence of their bearish stand points. IMO and the opinion of those who hold; the market has been wrong. The Share Price is wrong. This valuation is nonsense and it will not last and Hemogenyx have the cash to wait for that to happen.
Highly recommend everyone makes the effort to attend the Zoom tomorrow and see the progress Hemo have made from Vlad himself, then go look at the mCap and ask yourself if you think it will stay this low forever.
Have been in VRNA and PXS for 12 years plus, still pretty confident these will pay off in the long run (well already up in PXS, but not seeing the gains I want yet).
It's Pharma, just need a little patience...
Appreciate a lot of you were sucked in by the happy clappers who were almost guaranteeing the globalco deal would happen, because, by their own words "why wouldn't it?". And now the happy clappers are using the same language as those who challenged them at the time, like "Cashflow is always a constant issue. Delays are inevitable."
Can you imagine saying that a year ago? The people who are saying it now would have been first to jump up and down on you followed by the rest of the mob...
Would just advise you to hang on, and average down when you can. And spread you risk by investing elsewhere.
Glalth...
HFH ... Thank you for a very sensible write up on what has happened in the past. I do feel we have past the worst times and mistakes were also made by HEMO. Nevertheless, easy to say as an armchair investor without any of the dynamics and realities of bringing medicine to market. I am hoping some real updates come soon since what I fail to understand here is why even small time investors don't invest at this low price. What are they waiting for? What will be needed for this rerate since 2023 is a long way away and many cant hold large blocks of money locked away as that is not an investment strategy (well not for me).
So with a potential important webinar tomorrow, I would have thought a rerate by now so can someone tell me what is stopping people investing in this and rather trade in companies like NNN which have no product line at all (but up nearly 100% in 2 days !!!)..... something we can only dream for here.
HT Whilst we are all frustrated with continued delays it’s important to remember why they have occurred. If you take the CDX antibody, firstly there was a delay of over a year due to Covid, then a further delay whilst Hemogenyx negotiated the IP licensing agreement with Eli Lilly. The positive from this position is that they now own all the IP and you would assume they would not be developing a Master Cell line with Selexis if they didn’t think the product candidate was viable. On CBR, whilst it may just be proven ‘in a dish’ as you eloquently put it, again it’s important to remember that the delay in this case was due to Hemogenyx spending nearly a year compiling a very comprehensive seminal patent application to protect all IP on the approach before progressing. One might argue this was a very sensible approach. They have now allocated funding and in vitro results are imminent. Finally on HEMO CAR-T. Again, it was prudent of Vlad not to commence building the clean room CAR manufacturing facilities until they had the FDA validate their approach. Unfortunately these discussions were put back by the FDA from February until May. The positive is the feedback was very encouraging, Hemogenyx know what is required for IND approval, they have built the clean room required and have employed CAR staff and are employing more as we speak. So in summary whilst the delays are frustrating the bigger picture is that all product candidates ARE progressing to human clinical trials, albeit not as quickly as everyone would like. We just need patience. The candidates are viable and that means in time Hemogenyx will substantially rerate and all will be well for holders. Again Hemogenyx have enough money to achieve proof of concept for at least one product candidate and that alone is massive in this current bear market. Just my take.
Everyone knows this already. We are all down. You are bitter?
Do you see the end game? Do you think they will never get there?
COVID really did make things difficult imo. The CLNs were an absolute mess in my view and smashed the SP for investors. The delays have been painful.
But this is junior pharma. HEMO have worked on a shoe string budget. Cashflow is always a constant issue. Delays are inevitable.
But I believe Vlad will make this work. He will make a success of HEMO and produce a successful drug and/or (hopefully and) drug production platform that will be in demand by big pharma and the like.
So whilst slipping timescales are irritating, I am happy to wait. I see progress being made. I see our USP. CBR/HEMO CAR T/CDX are game changers for me. They just have to keep moving things forward to rerate the SP.
I accept it will take as long as it takes. Naively or otherwise. I shall remain patient and confident.
I have been here over 3 years pingu, so longer than you .....and have been lead a merry dance of promises over that period...I originally was holding for CDX deal with globalco, well that went south, then hung my hat on CAR-T being in trials this year....which how is not until next....it seems like the carrot gets dangled , but the SP is so low we are ALL and I mean ALL in a loss situation...